Literature DB >> 29860712

Medication-related osteonecrosis of the jaw incidence in patients exposed concomitantly to bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors: is it generalizable to all solid tumors?

Kadri Altundag1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29860712     DOI： 10.1007/s00520-018-4301-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  1 in total

1.  Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors.

Authors:  T van Cann; T Loyson; A Verbiest; P M Clement; O Bechter; L Willems; I Spriet; R Coropciuc; C Politis; R O Vandeweyer; J Schoenaers; P R Debruyne; H Dumez; P Berteloot; P Neven; K Nackaerts; F J S H Woei-A-Jin; K Punie; H Wildiers; B Beuselinck
Journal:  Support Care Cancer       Date:  2017-09-30       Impact factor: 3.603
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.